Adaptive Biotechnologies Corp SEC filings ADPT
Adaptive Biotechnologies Corp has 832 filings in SEC EDGAR's recent list, going back to Dec 28, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| S-8 | Employee stock plan registration | Feb 14, 2023 | — |
| 424B7 | Filing | Aug 21, 2020 | — |
| 424B5 | Prospectus supplement | Jul 16, 2020 | — |
| 424B5 | Prospectus supplement | Jul 14, 2020 | — |
| S-3ASR | Automatic shelf registration | Jul 14, 2020 | — |
| 424B4 | Prospectus | Jan 24, 2020 | — |
| S-1/A | Amended registration statement | Jan 22, 2020 | — |
| S-1 | Registration statement | Jan 21, 2020 | — |
| S-8 | Employee stock plan registration | Jul 1, 2019 | — |
| 424B4 | Prospectus | Jun 27, 2019 | — |
| S-1/A | Amended registration statement | Jun 26, 2019 | — |
| S-1/A | Amended registration statement | Jun 19, 2019 | — |
| S-1/A | Amended registration statement | Jun 17, 2019 | — |
| S-1 | Registration statement | May 30, 2019 | — |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ADPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- WA
- Headquarters
- Seattle, WA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1478320
- Former names
- Adaptive TCR Corp (until Jun 2, 2011)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.